CBN-A1000

N/A

Report date: 2023/12/19 10:11:55

Base Information

Drug NameCBN-A1000
Drug Alias NameCBN-A1000CGT-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulatorsGene transference
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarbon Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarbon Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A